ORLADEYO
Identification of Orladeyo
| No description |
Google image searchProduct monograph
Active ingredient
berotralstat (berotralstat hydrochloride), 150 MG
DIN: 02527693
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: BIOCRYST PHARMACEUTICALS INC
Date: 06-SEP-2022
ATC:
- B06 — OTHER HEMATOLOGICAL AGENTS (ATC, ATC/DDD, )
- B06A — OTHER HEMATOLOGICAL AGENTS (ATC, ATC/DDD)
- B06AC — Drugs used in hereditary angioedema (ATC, ATC/DDD)
- B06AC06 — BEROTRALSTAT (ATC/DDD)
Reference brand drug: Orladeyo
